Published: May 10, 2021
NEW YORK, May 10, 2021 (GLOBE NEWSWIRE)
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, today reported financial results for the first quarter ended March 31, 2021.
“We continued to make significant strides in the quarter toward becoming a premier biopharmaceutical company focused on delivering potentially life-changing medicines to people living with serious CNS conditions. We successfully filed our NDA for AXS-05 for the treatment of MDD with the FDA, which was granted Priority Review, and are on track to file our NDA for AXS-07 for the acute treatment of migraine this quarter,” said Herriot Tabuteau, MD, Chief Executive Officer of Axsome. “Pre-commercial activities are intensifying as planned to ensure launch readiness assuming FDA approval. The rest of our pipeline continues to progress with the anticipated initiation of the plann
AXS-07 for migraine, NDA submission (2Q 2021)
AXS-05 for smoking cessation, FDA meeting (3Q 2021)
AXS-05 for MDD, commercial launch, if approved (2H 2021)
Clinical Trial Readouts:
Clinical Trial Initiations:
Upcoming Scientific Conferences
International Society for Pharmacoeconomics and Outcomes Research (ISPOR) annual meeting, May 17-20, 2021
American Society for Clinical Psychopharmacology (ASCP) annual meeting, June 1-4, 2021
American Headache Society (AHS) annual meeting, June 3-6, 2021
Upcoming Investor Conferences
BofA Health Care Conference, May 11, 2021 (to be webcast)
RBC Capital Markets Global Healthcare Conference, May 18, 2021 (to be webcast)
UBS Global Healthcare Virtual Conference, May 24, 2021 (to be webcast)
William Blair Growth Stock Conference, June 3, 2021 (to be webcast)
First Quarter 2021 Financial Results
Bandwidth to Participate in Upcoming Investor Conferences
News provided by
Share this article
Share this article
RALEIGH, N.C., May 7, 2021 /PRNewswire/ Bandwidth Inc. (NASDAQ: BAND), a leading global enterprise cloud communications company, today announced its scheduled participation at the following upcoming virtual investor conferences:
JP Morgan Global Technology, Media and Communications Conference – Fireside chat with David Morken, CEO on Monday, May 24, 2021 at 11:00am Eastern Time.
William Blair Growth Stock Conference – Fireside chat with David Morken, CEO on Wednesday, June 2, 2021 at 9:00am Eastern Time.
Baird Global Consumer, Technology & Services Conference –
Marina Carreker, President and Jeff Hoffman, CFO will be hosting investor meetings on Thursday, June 10.